cagrilintide semaglutide combination phase 3 2024 New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk Novo Nordisk's Cagrilintide shows promising

Bath with an anti-itch solution

doi: 10.1016/j.parkreldis.2013.11.008

Angiogenesis and nutrient delivery Vascular network importance: Healing tissues require increased metabolic support (oxygen, glucose, amino acids, minerals)

Funding This work was supported by Health Commission of Anhui Province (AHWJ2021b111), Health Commission of Fuyang City (2021-1), and Anhui Medical University Fund Project (2021xkj210)

Warning Do not use vitamin 12 injection if you are allergic to vitamin b12 or cobalt

The deltoid is easily accessible without needing to undress the patient extensively, making it a convenient site for quick and effective injections, especially in outpatient settings